DDIT3 and diffuse large B-cell lymphoma: Furthermore, the incidence of TLS within the subset of patients with DLBCL and HGBCL in our cohort aligns closely with an international dataset of DLBCL patients treated with DA‐EPOCH‐R or R‐CHOP.27